Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

11.61USD
8:59pm GMT
Change (% chg)

$-0.01 (-0.09%)
Prev Close
$11.62
Open
$11.36
Day's High
$11.85
Day's Low
$11.34
Volume
153,837
Avg. Vol
183,430
52-wk High
$20.65
52-wk Low
$8.07

Select another date:

Thu, Nov 8 2018

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount

Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.

Coherus prices biosimilar to Amgen's Neulasta at 33 pct discount

Nov 8 Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.

BRIEF-Coherus Prices Public Offering Of Common Stock

* SAYS PUBLIC OFFERING OF 5.17 MILLION COMMON SHARES PRICED AT $14.50PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Coherus Announces Proposed Public Offering Of Common Stock

* COHERUS BIOSCIENCES INC SAYS COMMENCED UNDERWRITTEN PUBLIC OFFERING OF $75,000,000 OF SHARES OF ITS COMMON STOCK Source text for Eikon: Further company coverage:

Select another date: